SCHEMBL14907002

SCHEMBL14907002

O=C(N/N=C/c1c(O)cc(Cl)cc1Cl)c1cc(O)c(O)c(O)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
L3MBTL1 Q9Y468 2/20 0.50
MEN1 O00255 1/20 0.50
NPC1 O15118 1/20 0.50
USP2 O75604 1/20 0.50
KMT2A Q03164 1/20 0.50
MCOLN3 Q8TDD5 1/20 0.50
POLB P06746 2/20 0.49
GAA P10253 2/20 0.49
ALDH1A1 P00352 1/20 0.49
MAPT P10636 1/20 0.49
THRB P10828 1/20 0.49
APEX1 P27695 1/20 0.49
MPI P34949 1/20 0.49
RECQL P46063 1/20 0.49
BLM P54132 1/20 0.49
PIK3CG P48736 1/20 0.47
SPHK2 Q9NRA0 3/20 0.47
GCGR P47871 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14906911 0.89 GCGR (0.54) KDM4ETDP1L3MBTL1MEN1NPC1
SCHEMBL14906890 0.86 GCGR (0.53) KDM4ETDP1L3MBTL1MEN1NPC1
SCHEMBL685235 0.85 KDM1A (0.54) KDM4ETDP1L3MBTL1MEN1NPC1
SCHEMBL14907120 0.85 GCGR (0.55) KDM4ETDP1L3MBTL1MEN1NPC1
SCHEMBL14906895 0.83 MEN1 (0.70) KDM4ETDP1L3MBTL1MEN1NPC1
SCHEMBL14906903 0.81 PIK3CG (0.53) KDM4ETDP1L3MBTL1MEN1NPC1
SCHEMBL14906905 0.80 GCGR (0.54) KDM4EMEN1NPC1KMT2AALDH1A1
SCHEMBL14907021 0.80 PIK3CG (0.56) KDM4ETDP1L3MBTL1MEN1NPC1
SCHEMBL14907000 0.80 RAB9A (0.64) KDM4ETDP1L3MBTL1MEN1NPC1
SCHEMBL14907028 0.78 GCGR (0.61) MEN1KMT2APOLBGCGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9873661-B2 Small molecule malarial Aldolase-TRAP enhancers and glideosome inhibitors NEW YORK UNIVERSITY (US) 2018-01-23 US disclosed
US-20140275088-A1 SMALL MOLECULE MALARIAL ALDOLASE-TRAP ENHANCERS AND GLIDEOSOME INHIBITORS THE JOHNS HOPKINS UNIVERSITY 2014-09-18 US disclosed
WO-2013063243-A1 SMALL MOLECULE MALARIAL ALDOLASE-TRAP ENHANCERS AND GLIDEOSOME INHIBITORS NEW YORK UNIVERSITY (US) 2013-05-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140275088-A1 SMALL MOLECULE MALARIAL ALDOLASE-TRAP ENHANCERS AND GLIDEOSOME INHIBITORS ALDOA, DERA, TALDO1 KDM4E 283/4885TDP1 1088/4885L3MBTL1 363/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.